Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
10.09.2025 00:36:01
|
Eli Lilly Launches Global "Brain Health Matters" Campaign With Julianne Moore
(RTTNews) - Eli Lilly and Company (LLY) has launched Brain Health Matters, a global initiative encouraging proactive steps to support brain health and reduce dementia risk, including Alzheimer's disease.
The multi-year campaign builds on 35 years of Lilly's research and aims to make brain health a regular part of long-term wellness planning.
Actress and advocate Julianne Moore has partnered with Lilly in the U.S. to raise awareness, particularly among women, who represent nearly two-thirds of Alzheimer's cases.
Drawing from her role in Still Alice and her advocacy work, Moore will encourage individuals to discuss dementia risk, annual cognitive assessments, and lifelong brain health habits with their doctors.
Lilly Neuroscience president Anne E. White said early and regular assessments are critical as Alzheimer's can begin decades before symptoms appear. She emphasized that open conversations can help reduce stigma and allow people to take meaningful action sooner.
Moore added that proactive care is key to preserving independence and the ability to enjoy meaningful activities, urging people to prioritize brain health.
Launched during World Alzheimer's Month, the campaign offers educational resources, tools for building cognitive health plans, and guidance on lifestyle changes. It will run on U.S. television, digital, and audio platforms, alongside events, social media content, and an informational website, with plans for global expansion.
Tuesday LLY closed at $750.61, up 1.62%, and traded after hours at $747.50, down 0.41%, on the NYSE.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
23.09.25 |
Eli Lilly boss brands UK ‘worst country in Europe’ for cheap drug prices (Financial Times) | |
23.09.25 |
S&P 500-Wert Eli Lilly-Aktie: So viel hätten Anleger mit einem Investment in Eli Lilly von vor 3 Jahren verdient (finanzen.at) | |
17.09.25 |
ANALYSE-FLASH: Berenberg senkt Eli Lilly auf 'Hold' - Ziel runter auf 830 Dollar (dpa-AFX) | |
16.09.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Verlust hätte eine Eli Lilly-Investition von vor einem Jahr eingebracht (finanzen.at) | |
09.09.25 |
S&P 500-Wert Eli Lilly-Aktie: So viel Gewinn hätte ein Investment in Eli Lilly von vor 10 Jahren eingebracht (finanzen.at) | |
02.09.25 |
S&P 500-Wert Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 5 Jahren eingefahren (finanzen.at) | |
26.08.25 |
NYSE-Handel: S&P 500 verbucht schlussendlich Gewinne (finanzen.at) | |
26.08.25 |
Handel in New York: S&P 500 steigt am Nachmittag (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 617,10 | -0,13% |
|